FDA public meeting on FSD.

By on

The FDA is having a two day public meeting and scientific workshop on Female Sexual Dysfunction (FSD) this week. The FDA is interested in obtaining patient input on the impact of the most common form of FSD (low desire and arousal). They are also interested in learning from women the effectiveness of the treatments that …

Continue Reading